Main Article Content
Abstract
ABSTRACT
Background. Hirsutism is the excessive terminal hair growth in androgen-dependent areas of the body in women, which grows in a typical male distribution pattern. This phenomenon results from simultaneous action of testosterone on the hair follicle and the sebaceous gland. The objective of this work was to establish a correlation between severity of hirsutism and testosterone levels in this group of women. Materials and Methods. We conducted a prospective descriptive cross-sectional study, setting at Yaounde central hospital in the endocrinology unit. Participants were recruited by convenience sampling. The Ferriman and Gallway score was used for clinical classification of hirsutism. We measured total plasma testosterone using enzyme immunoassay ELISA. Spearman test was used to assess correlation between the study parameters. Results. Our study population consisted of 69 women aged 18 to 48 years. Hirsutism was mild in 63.7% (44/69) of women; moderate in 36.2% (25/69) of women. No women had severe hirsutism. Mean testosterone was 1.36 ± 1.00 ng / mL: 91.7% (66/69) of women with testosterone greater than 0.6 ng / mL. There was a weak but not significant negative correlation between degree of hirsutism and plasma total testosterone concentration (r: -0.178, p: 0.138). Conclusion. In women with mild or moderate hirsutism, the degree of hirsutism does not reflect total testosterone levels.
RÉSUMÉ
Introduction. L'hirsutisme est la croissance excessive des poils dans les zones du corps dépendant des androgènes chez les femmes, qui se développe dans un schéma de distribution masculine typique. Ce phénomène résulte de l'action simultanée de la testostérone sur le follicule pileux et la glande sébacée. L'objectif de ce travail était d'établir une corrélation entre la sévérité de l'hirsutisme et les niveaux de testostérone dans ce groupe de femmes. Matériels et méthode. Nous avons mené une étude prospective descriptive transversale dans l'unité d'endocrinologie de l’hôpital central de Yaoundé. Les participantes ont été recrutées par échantillonnage de convenance. Le score de Ferriman et Gallway a été utilisé pour la classification clinique de l'hirsutisme. Nous avons mesuré la testostérone plasmatique totale en utilisant un test immuno-enzymatique ELISA. Le test de Spearman a été utilisé pour évaluer la corrélation entre les paramètres de l'étude. Résultats. Notre population d'étude était composée de 69 femmes âgées de 18 à 48 ans. L'hirsutisme était léger chez 63,7% (44/69) des femmes ; modérée chez 36,2% (25/69) des femmes. Aucune femme ne souffrait d'hirsutisme grave. La testostérone moyenne était de 1,36 ± 1,00 ng / mL; 91,7% (66/69) des femmes ayant une testostérone supérieure à 0,6 ng / ml. Il y avait une corrélation négative faible mais non significative entre le degré d'hirsutisme et la concentration plasmatique totale de testostérone (r : -0,178, p: 0,138). Conclusion. En cas d’hirsutisme léger ou modéré, le degré d'hirsutisme ne reflète pas les niveaux totaux de testostérone.
Keywords
Article Details
References
- Rittmaster R, Loriaux D. Hirsutism. Ann Intern Med. 1987 Jan;106(1):95–107.
- Azziz R, Sanchez L, Knochenhauer E, Moran C, Lazenby J, Stephens K. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients. J Clin Endocrinol Metab. 2004 Feb;89(2):453–62.
- Pugeat M, Déchaud H, Raverot V, Denuzière A, Cohen R, Boudou P. Recommandations pour l’exploration des hyperandrogénies. Ann Endocrinol. 2010 Fevrier;7(1):e3–8.
- Ferriman D, Gallwey G. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:14407.
- Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pr Res Clin Endocrinol Metab. 2006;20:177–91.
- Abraham GE. Radioimmunoassay of steroids in biological fluids. Clin Biochem. 1974;7:193–201.
- Taieb J. Exploration biologique de la fonction androgénique chez la femme : problèmes liés aux immunodosages des androgènes. Médecine Reprod. 2012;14(3):196–203.
- Taieb J, Mathian B, Millot F, Patricot MC. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49:1381–95.
- Carmina E, Koyama L, Chang L, Lobo L. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 1992;167:1807-12.
- Pavičić Baldani D, Škrgatić L, Bukvić M, Trgovčić I. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Acta Dermatovenerol Croat ADC. 2013;21(2):105–12.
- Karrer-Voegeli S, Rey F, Reymond MJ. Androgen Dependence of Hirsutism, Acne, and Alopecia in Women: Retrospective Analysis of 228 Patients Investigated for Hyperandrogenism. Med Baltim. 2009 Jan;88(1):32– 45.
- Sawaya ME, Shalita. Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne. J Cutan Med Surg. 1998Jul;3(1):9–15.
- Castellano JM, Bentsen A, Mikkelsen JD, Tena-Sempere M. Bridging energy homeostasis and reproduction. Brain Res. 2010 Dec;1364:129–38.
References
Rittmaster R, Loriaux D. Hirsutism. Ann Intern Med. 1987 Jan;106(1):95–107.
Azziz R, Sanchez L, Knochenhauer E, Moran C, Lazenby J, Stephens K. Androgen Excess in Women: Experience with Over 1000 Consecutive Patients. J Clin Endocrinol Metab. 2004 Feb;89(2):453–62.
Pugeat M, Déchaud H, Raverot V, Denuzière A, Cohen R, Boudou P. Recommandations pour l’exploration des hyperandrogénies. Ann Endocrinol. 2010 Fevrier;7(1):e3–8.
Ferriman D, Gallwey G. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:14407.
Stanczyk FZ. Diagnosis of hyperandrogenism: biochemical criteria. Best Pr Res Clin Endocrinol Metab. 2006;20:177–91.
Abraham GE. Radioimmunoassay of steroids in biological fluids. Clin Biochem. 1974;7:193–201.
Taieb J. Exploration biologique de la fonction androgénique chez la femme : problèmes liés aux immunodosages des androgènes. Médecine Reprod. 2012;14(3):196–203.
Taieb J, Mathian B, Millot F, Patricot MC. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49:1381–95.
Carmina E, Koyama L, Chang L, Lobo L. Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome. Am J Obstet Gynecol. 1992;167:1807-12.
Pavičić Baldani D, Škrgatić L, Bukvić M, Trgovčić I. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Acta Dermatovenerol Croat ADC. 2013;21(2):105–12.
Karrer-Voegeli S, Rey F, Reymond MJ. Androgen Dependence of Hirsutism, Acne, and Alopecia in Women: Retrospective Analysis of 228 Patients Investigated for Hyperandrogenism. Med Baltim. 2009 Jan;88(1):32– 45.
Sawaya ME, Shalita. Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne. J Cutan Med Surg. 1998Jul;3(1):9–15.
Castellano JM, Bentsen A, Mikkelsen JD, Tena-Sempere M. Bridging energy homeostasis and reproduction. Brain Res. 2010 Dec;1364:129–38.